| Interspecies scaling: role of protein binding in the prediction of clearance from animals to humans. | |
| | |
MedLine Citation:
|
PMID: 11185664 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The objective of this study is to evaluate whether unbound clearance of a drug can be predicted more accurately than total clearance using the allometric approach and if there is any real advantage of predicting unbound clearance over total clearance. The total and unbound clearance of 20 randomly selected drugs were scaled up from the animal data (at least three animal species) obtained from the literature. Three methods were used to generate plots to scale up the clearance values: (1) total or unbound clearance versus body weight (simple allometric equation), (2) the product of total or unbound clearance and maximum life span potential (MLP) versus body weight, and (3) the product of total or unbound clearance and brain weight versus body weight. The results of this study indicate that there will be instances when unbound clearance can be predicted better than total clearance or vice versa. In conclusion, unbound clearance cannot be predicted any better than total clearance. |
| | |
Authors:
|
I Mahmood |
Related Documents
:
|
3180634 - The influence of nonsteroidal anti-inflammatory drugs and probenecid on the renal respo... 6726634 - Excretion, distribution, and metabolism of primaquine in rats. 3719894 - The clinical pharmacology of mitozantrone. 6128714 - Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate... 18057794 - preparation and release profile of colon-targeting drug delivered as novel one-step dry... 8853234 - Validity of self-reported drug use in high risk populations: a meta-analytical review. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of clinical pharmacology Volume: 40 ISSN: 0091-2700 ISO Abbreviation: J Clin Pharmacol Publication Date: 2000 Dec |
Date Detail:
|
Created Date: 2000-12-11 Completed Date: 2000-12-22 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0366372 Medline TA: J Clin Pharmacol Country: United States |
Other Details:
|
Languages: eng Pagination: 1439-46 Citation Subset: IM |
Affiliation:
|
Division of Pharmaceutical Evaluation I, Office of Clinical Pharmacology and Biopharmaceutics, Food and Drug Administration, Rockville, Maryland 20852, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Drug Design* Humans Metabolic Clearance Rate Models, Animal Pharmacokinetics* Protein Binding Species Specificity |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pharmacokinetics/pharmacodynamics in drug development: an industrial perspective.
Next Document: Iron supplementation in preterm infants: a study comparing the effect and tolerance of a Fe2+ and a ...